Vaccines: The World Market

Vaccines: The World Market
全球疫苗市场研究报告

发布时间：2007.2.1

内容介绍

What are the trends that are fueling a new boom in vaccine production and sales? Why is an industry so commonly associated with children finding an increasing marketplace among adult populations? What makes this class of drugs likely to grow at a faster rate than other pharmaceutical products? These are among the questions answered in Kalorama’s in-depth report, Vaccines: The World Market.

With the historic success of vaccines in virtually eliminating diseases such as small pox and polio, and with their obvious benefit of preventing disease before it occurs, vaccines are a 9 billion dollar industry and new vaccines continue to be developed. Kalorama’s Vaccines: The World Market breaks down the market for pediatric and adult vaccines, providing background information, revenue numbers, and a discussion of critical trends that anyone seeking opportunities in vaccines will need to be aware of. Among the exhaustive information in this report, the following topics are discussed in detail:

Current and Forecasted Revenue Figures to 2012 for strategic planning and new product consideration.
Over 55 Tables and Figures for easy access to decision support information in proposals, internal memos and business plans.
Round-up of Key Vaccine Companies for benchmarking and marketplace knowledge.
Discussion of Major Issues and Trends such as vaccine safety and legislation affecting the market; current vaccine companies can use to plan, new entrants can use to quickly bring themselves up to speed on the marketplace and steer clear of problem areas.
Review of the Robust Vaccine Pipeline (nearly 200+ drugs in development) and how they are expected to affect the market, so that executives can adjust business decisions to the most likely market scenario.
Current revenues and revenue forecasts to 2012 are included for the following pediatric vaccine categories:

DTaP & DTP Vaccines
Hep Vaccines
HiB Vaccines
MMR Vaccines
Combination Vaccines
Pneumococcal Vaccines
Polio Vaccines
Varicella Vaccines
Other Pediatric Vaccines
As well as Revenues and Forecasts to 2012 for the following adult vaccine categories:

Influenza Vaccines
Hepatitis Vaccines
Pneumococcal Vaccines
Travel, DT and other Adult Vaccines

Additionally, this report provides current market size and forecasts the following cancer vaccines:

Breast Cancer
Cervical Cancer
Colon/Rectal Cancer
Lung
Melanoma
Prostate
Other cancers.
Kalorama’s trusted information-gathering process provides the most accurate study of the market for vaccines available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies. While financial reports, major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Sales, Marketing, Business Development and Strategic Planning executives in the pharmaceutical industry, advertising agencies and consulting groups who work with pharmaceutical clients as well as institutional librarians are among those who will benefit from Kalorama’s detailed analysis of the vaccine market.

As part of its detailed coverage, Kalorama’s Vaccines: The World Market features profiles of the following companies:

Acambis plc
AlphaVax, Inc.
Avant Immunotherapeutics
Bavarian Nordic A/S
Baxter Healthcare
Berna Biotech AG
Emergent Biosolutions
GlaxoSmithKline
MEDIMMUNE
Merck & Co. Inc
Nabi Biopharmaceuticals
Novartis
PFIZER
Pharmexa
SANOFI Pasteur
Vical
Wyeth
目录及图表

Chapter One: Executive Summary

Scope And Methodology
Overview
Pediatric Preventative Vaccines
The Market

Adult Preventative Vaccines
The Market

Total Preventative Market
Emerging Cancer Vaccines
The Market

Issues and Trends
Chapter Two: Introduction to Vaccines

A Brief History: The Development of Vaccines
The Immune Response
Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines

Vaccine Approval Process
Chapter Three: Pediatric Preventive Vaccines

Introduction
Childhood Immunization in the United States
Childhood Immunization Rates
Challenges to the Vaccine Delivery System
Recommended Childhood Immunization Schedule

Pediatric Vaccine Products
BCG Vaccines
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio Vaccines
Haemophilus Influenzae Type B Vaccines
Hepatitis A Vaccines
Measles, Mumps and Rubella Vaccines
Pneumococcal Conjugate Vaccine
Rotavirus Vaccines
Varicella Vaccines

Cost of Vaccines in the United States
Pediatric Vaccines in Development
Global Initiatives for Vaccine Research
Diarrhea-Related Diseases
Acute Respiratory Infections
Other Conditions

The World Market for Pediatric Preventive Vaccines
Total Market Size and Forecast
DTP and DTaP Vaccine Market
Hepatitis Vaccine Market
Haemophilus Influenzae Type B Vaccine Market
Measles, Mumps and Rubella Vaccines
Combination Vaccines Market
Pneumococcal Vaccine
Poliovirus Vaccine
Varicella Vaccines
Other Vaccines Market
Chapter Four: Adult Preventive Vaccines

Introduction
Adult Vaccine-Preventable Diseases: Facts and Figures
Global Virological Surveillance Program
Recommendations for Adult Immunizations
Vaccine Recommendations for International Travel
CDC’s Recommendations for Yellow Fever Vaccination
WHO International Health Regulations

Adult Vaccine Products
BCG Vaccines
Cholera Vaccines
Diphtheria-Tetanus Vaccines
Hepatitis Vaccines
Influenza Vaccines
Japanese Encephalitis Vaccine
Pneumococcal Disease Vaccines
Rabies Vaccine
Typhoid Vaccines
Yellow Fever Vaccines

Adult Vaccines in Development
Global Initiatives for Vaccine Research
Cholera
Dengue Fever
Epstein-Barr Virus
HIV/AIDS
Helicobacter Pylori
Hepatitis
Herpesvirus
Leishmaniasis
Malaria
Severe Acute Respiratory Syndrome
Shigella
West Nile Virus

The World Market for Adult Preventive Vaccines
Total Market Size and Forecast
Hepatitis Market
Influenza Vaccine Market
Travel, DT, and Miscellaneous Vaccine Market
Chapter Five: Preventive Vaccines Market Summary

Trends Driving the Preventive Vaccines Market
Market Size and Forecast
Vaccine Market Competitors
Pediatric Vaccines
Adult Vaccines
Chapter Six: Emerging Cancer Vaccines

History and Growth of the Cancer Treatment Market
Cancer Vaccine Technology
Antigen/Adjuvant Vaccines
Whole Cell Tumor Vaccines
Dendritic Cell (DC) Vaccines
Viral Vectors and DNA Vaccines
Idiotype Vaccines
Types of Therapeutic Vaccines

Cancer Statistics
Available Cancer Vaccines
Bladder Cancer
Cervical Cancer
Colorectal Cancer
Melanoma

Types of Cancers Susceptible to Vaccines
Breast Cancer
Gastrointestinal Cancer
Kidney
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma
Neuroblastoma
Ovarian Cancer
Prostate Cancer
Sarcoma

Cancer Vaccine Pipeline
Colorectal Cancer
Lung Cancer
GV-1001
Lymphoma
Melanoma
Prostate Cancer
Other Cancers
Telomerase

The Emerging Cancer Vaccine Market
Total Market Size and Forecast
Competitor Analysis
Chapter Seven: Issues and Trends

Vaccine Safety
Pre-licensure Evaluation
Post-Licensure Surveillance
The Vaccine Injury Compensation Program
World Health Organization
Other Initiatives
The Future of Vaccine Safety

Vaccine Shortages
Preventing Future Shortages in the U.S.
Addressing Shortages in Developing Nations

Preventing Pandemics
Vaccines and Bioterrorism
Overview
Project Bioshield Act of 2004
National Bio and Agro-Defense Facility
Anthrax
Smallpox
Plague
Botulism
Tularemia
Viral Hemorrhagic Fevers

Innovations in Vaccine Delivery Systems
Edible Vaccines
Mucosal Delivery
Intranasal Delivery
Oral Vaccines
Vaccine Patches
chapter eight: Company Profiles

Acambis plc
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

AlphaVax, Inc.
History and Lines of Business
Strategic Alliances
Vaccine Products

Avant Immunotherapeutics
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Bavarian Nordic A/S
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Baxter Healthcare
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Berna Biotech AG
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Emergent biosolutions
History and Lines of Business
Strategic Acquisition and Alliance
Vaccine Products
Financial

GlaxoSmithKline
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Medimmune
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Merck & Co. Inc
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Nabi Biopharmaceuticals
History and Lines of Business
Strategic Alliance
Vaccine Products
Financial Information

Novartis
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Pfizer
History and Lines of Business
Vaccine products
Financial Information

Pharmexa
History and Lines of Business
Vaccine Products
Financial Information

Sanofi Pasteur
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

Vical
History and Lines of Business
Strategic Alliances
Technology Platform
Therapeutic Cancer Vaccine Products in Clinical Trials
Financial Information

Wyeth
History and Lines of Business
Vaccine Products
Financial Information
Appendix: Company Directory

LIST OF EXHIBITS

Chapter One: Executive Summary

Figure 1-1: World Market Pediatric Vaccines by Current and Emerging Markets 2003-2012
Figure 1-2: World Market Adult Vaccines by Current and Emerging Markets 2003-2012
Figure 1-3: World Market Cancer Vaccines by Current and Emerging Markets 2003-2012
Chapter Two: Introduction to Vaccines

Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2005
Table 2-2: Vaccine-Preventable Diseases
Chapter Three: Pediatric Preventive Vaccines

Table 3-1: Global Immunization Rates by Vaccine Type 2005
Table 3-2 : Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1999-2005
Table 3-3: U.S. Recommended Childhood Immunization Schedule, 2006
Table 3-4: Cost of Vaccines: Private Sector Versus Public Sector Prices Last Reviewed/Updated, September 2006 (Vaccine, Brand Name, Packaging, CDC Cost/Dose, Private Sector Cost/Dose, Contract End Date, Manufacturer)
Table 3-5: Selected Pediatric Vaccines in Development (Company, Product Name, Indication, Development Status)
Table 3-6: World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others)
Figure 3-1: Market Share of Pediatric Vaccines by Type 2005
Figure 3-2: Market Share of Pediatric Vaccines, by Type 2012
Table 3-7: World DTP and DTaP Vaccine Market 2003-2012
Table 3-8: World Pediatric Hepatitis Vaccine Market 2003-2012
Table 3-9: World Hib Vaccine Market, 2003-2012
Table 3-10: World MMR Vaccines Market 2003-2012
Table 3-11: World Combination Vaccines Market 2003-2012
Table 3-12: World Pediatric Pneumococcal Vaccine Market 2003-2012
Table 3-13: World Poliovirus Vaccine Market 2003-2012
Table 3-14: World Varicella Vaccine Market 2003-2012
Table 3-15: Other Vaccines Market 2003-2012
Chapter Four: Adult Preventive Vaccines

Table 4-1: Universal Adult Immunization Schedule 2006
Table 4-2: Adult Immunization Schedule for Populations with Special Medical Conditions, 2006
Table 4-3 : Selected Adult Preventive Vaccines in Development, 2007 (Company, Product Name, Indication, Development Status)
Table 4-4: World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2003-2012
Figure 4-1: Market Share of Adult Vaccines, by Type, 2005
Figure 4-2: Market Share of Adult Vaccines, by Type, 2012
Table 4-5: World Hepatitis Vaccine Market 2003-2012
Table 4-6: World Influenza Vaccine Market 2003-2012
Table 4-7: U.S. Influenza Vaccination Rates by Age and Risk Group 2004 - 2005
Table 4-8: CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs 2010)
Table 4-9: 2005 Estimated Population by Region and Selected Age Group Population
Table 4-10: World Pneumococcal Vaccine Market 2003-2012 Chapter Five: Preventive Vaccines Market Summary
Figure 5-1: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market
Table 5-1: The World Vaccines Market by Vaccine Type 2003-2012
Figure 5-2: World Market for Vaccines Share by Type, 2003, 2007 and 2012
Table 5-2: Major Manufacturers’ Shares of the World Vaccine Market, 2005
Figure 5-3: 2005 World Vaccines Market Share, by Leading Competitors
Table 5-3: Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2005
Figure 5-5: Market Share of Pediatric Vaccines Market, 2005
Table 5-4: Major Manufacturer’s Shares of the World Adult Vaccine Market 2005
Figure 5-6: Market Share of Adult Vaccines Market 2005
Chapter Six: Emerging Cancer Vaccines

Table 6-1: Estimated and Projected World Cancer Incidence by Selected Types of Cancer (Lung, Breast, Colon/Rectum, Stomach, Liver, Prostate, Cervix, Esophogus, Lymphoma, Pancreas, Melanoma), 2005 and 2020
Figure 6-1: Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2005 and 2020
Table 6-2: Estimated and Projected World Cancer Mortality by Selected Types of Cancer (Lung, Breast, Colon/Rectum, Stomach, Liver, Prostate, Cervix, Esophogus, Lymphoma, Pancreas, Melanoma), 2005 and 2020
Figure 6-2: Estimated and Projected World Cancer Mortality by Selected Types of Cancer
Table 6-3: Total Cancer Incidence by Sex and Country, 2006 Estimates (in thousands)
Table 6-4: Estimated Cancer Incidence by World Region and Type of Cancer
Figure 6-4: Estimated Cancer Incidence by World Regions
Table 6-5: Malignant Conditions of the Skin
Table 6-6: Types of Primary Lung Cancer, Risk Factors, Percent of Cases
Table 6-7: Selected Cancer Vaccines in the Pipeline (Product Name, Developer, Indication, Development Phase, Earliest Approval Date)
Table 6-8: World Market Cancer Vaccines by Cancer Type (Cervical, Colon/Rectal, Lung, Melanoma, Prostate, Other) 2003-2012
Figure 6-5: Share of the Cancer Vaccine by Vaccine Indication, 2012
Chapter Seven: Issues and Trends

Table 7-1: Selected Companies/Laboratories Developing Biodefense Vaccines